MAPT and tauopathy: To evaluate the capacity of rat transgenic models to recapitulate essential features of human tauopathy, we generated a transgenic line that expresses the 441 amino acid human tau isoform (2N4R) bearing the P301S mutation, driven by the CaMKIIα promoter.